Covered recipient · General Payments record
JILLIAN C ALDERSON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neuromuscular Medicine
General Payments · PY2019–2024
$654.91
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.67 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $96.70 | 6 |
| ARGENX US, INC. | $48.66 | 3 |
| Acerta Pharma LLC | $20.62 | 1 |
| Amylyx Pharmaceuticals, Inc. | $18.84 | 1 |
| Lilly USA, LLC | $16.89 | 1 |
| UCB, Inc. | $16.76 | 1 |
| Novo Nordisk AS | $16.46 | 1 |
| ABBVIE INC. | $14.43 | 1 |
| Lundbeck LLC | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103199091 | CMS |
| Amylyx Pharmaceuticals, Inc. | $18.84 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148254019 | CMS |
| ARGENX US, INC. | $15.05 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112521 | CMS |
| ARGENX US, INC. | $16.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142108717 | CMS |
| ARGENX US, INC. | $17.30 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142122843 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.62 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105783436 | CMS |
| Lilly USA, LLC | $16.89 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135049922 | CMS |
| Lundbeck LLC | $13.31 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145890317 | CMS |
| Novo Nordisk Inc | $16.46 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096954232 | CMS |
| PFIZER INC. | $16.18 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131149372 | CMS |
| PFIZER INC. | $15.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131201970 | CMS |
| PFIZER INC. | $15.31 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131656205 | CMS |
| PFIZER INC. | $15.62 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131869792 | CMS |
| PFIZER INC. | $17.41 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131995033 | CMS |
| PFIZER INC. | $17.14 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877438 | CMS |
| UCB, Inc. | $16.76 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143277909 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.